Kidney Cancer Observational Protocol
2007 - Rene: Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Radical Nefrectomy/Tumorectomy Surgery
1 other identifier
observational
2,500
1 country
1
Brief Summary
The aim of this observational study is to gather pre and post surgery clinical data belonging to patients who underwent radical or partial nephrectomy and to evaluate the impact of the surgery on the quality of life of the patients, as well as possible relapses within a 10 year period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 27, 2010
CompletedFirst Submitted
Initial submission to the registry
October 10, 2023
CompletedFirst Posted
Study publicly available on registry
November 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 4, 2028
November 27, 2023
November 1, 2023
18 years
October 10, 2023
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical parameter collection
Collection intended for the purpose of implementing diagnostic and therepautic strategies for the management of the disease in both the patient enrolled in the study and for future cases.
10 years
Study Arms (1)
Experimental
Patients with kidney cancer who underwent radical or partial kidney removal surgery
Interventions
Removal of neoplastic mass either by full kidney excision or by targeted cancer removal
Eligibility Criteria
Patients with kidney cancer who underwent radical or partial nephrectomy
You may qualify if:
- years or older
- Kidney cancer diagnosis
- Indication to cancer removal through surgery
- Ability to read and sign the informed consent
You may not qualify if:
- Age \< 18 years
- Absence of kidney cancer
- Inability to read and sign the informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Ospedale San Raffaele
Milan, MI, 20132, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francesco Montorsi, MD
IRCCS Ospedale San Raffaele
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 10, 2023
First Posted
November 27, 2023
Study Start
January 27, 2010
Primary Completion (Estimated)
February 4, 2028
Study Completion (Estimated)
February 4, 2028
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share